References
- Gerdtham U-G, Johannesson M, Gunnarsson B, Marcusson M, Henriksson E The effect on drug spending of changes in treatment patterns. PharmacoEconomics 13(1), 127–134 (1998).
- Gerdtham U-G, Lundin D. Why did drug expenditure increase during the 90s? A decomposition of Swedish expenditure data. PhatmacoEconomics22(1), 29–42 (2004).
- Merlis M. Explaining the growth in prescription drug spending: a review of recent studies. Report prepared for the US Department of Health and Human Services. 8 August 2000. US Department of Health and Human Services, Washington DC, USA (2000).
- Morgan, SG. Quantifying components of drug expenditure inflation: the British Columbia seniors drug benefit plan. Health Serv. Res. 37(5), 1243–1266 (2002).
- Mueller C, Chawla AJ, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J. Pub. Health 87(10), 1626–1629 (1997).
- Steinberg EP, Gutierrez B, Momani A, Boscarino JA, Neuman P, Deverka Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Air. 19(2), 198–211 (2000).
- van lielen R, Peys F, Genaert J. The demographic impact on ambulatory pharmaceutical expenditure in Belgium. Health Poll 45(1), 1–14 (1998).
- Crown W, Ling D, Berndt E. Measuring the costs and benefits of pharmaceutical expenditures. Expert Rev Pharmacoeconomics Outcomes Res 2, 89–97 (2002).
- Dubois RVV, Chawla AJ, Neslusan CA, Smith MW, Wade S. explaining drug spending trends: does perception match reality. Health Aft: 19(2), 231–239 (2000).
- OECD Health Data. A software package for the international comparison of healthcare system, User's Manual. Version 1.01, Paris (2000).
- Svensk Lakemedelsstatistik Apoteket AB, Stockholm (2000).
- Cutler D, Meara E. The medical costs of the young and old: a forty year perspective. NBERworking paper 6114 (1997).